Resolution of severe cardiomyopathy in infantile Pompe disease
Authors:
- 21 November 2013
- journal article
- case report
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 25 (1) , 146-148
Abstract
Infantile Pompe disease is a rare inborn error of metabolism characterized by severe hypertrophic cardiomyopathy and generalised hypotonia occurring in infancy. We present a case of an infant with severe hypertrophic cardiomyopathy that resolved after treatment with enzyme replacement therapy.Keywords
This publication has 8 references indexed in Scilit:
- Terapia de reemplazo enzimático en la forma infantil de la enfermedad de Pompe: experiencia de un caso con 7 años de seguimiento en ArgentinaArchivos Argentinos de Pediatria, 2012
- Left Ventricular Geometry, Global Function, and Dyssynchrony in Infants and Children With Pompe Cardiomyopathy Undergoing Enzyme Replacement TherapyJournal of Cardiac Failure, 2011
- Treatment of infantile Pompe disease with alglucosidase alpha: the UK experienceJournal of Inherited Metabolic Disease, 2010
- Reversal of Cardiac Dysfunction after Enzyme Replacement in Patients with Infantile-Onset Pompe DiseaseThe Journal of Pediatrics, 2009
- Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe diseaseGenetics in Medicine, 2008
- Fractures in children with Pompe disease: a potentiallong-term complicationPediatric Radiology, 2007
- A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe diseaseThe Journal of Pediatrics, 2006
- Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trialNeuromuscular Disorders, 2005